About the Company
The Pacific Spaceport Complex – Alaska (PSCA), formerly known as the Kodiak Launch Complex (KLC), is a dual-use commercial and military spaceport for sub-orbital and orbital launch vehicles. The facility is owned and operated by the Alaska Aerospace Corporation, a corporation owned by the Government of Alaska, and is located on Kodiak Island in Alaska. The spaceport opened in 1998 and has supported 31 (up to January 2023) launches, most of those for the U.S. government. The site was closed for two years following a launch failure that caused significant damage to parts of the spaceport. It reopened in August 2016.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $KOD News
Kodiak Sciences Inc KOD
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss ...
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript
Kodiak Sciences Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, expectations were $-0.86. Kodiak Sciences ...
Kodiak Sciences Inc Registered Shs hosts conference call for investors
The company, Kodiak Sciences Inc Registered Shs, is set to host investors and clients on a conference call on 3/28/2024 1:50:59 PM. The call comes after the company's earnings, which are set to be ...
Kodiak Sciences (KOD) Price Target Increased by 11.84% to 4.34
Kodiak Sciences Background Information (This description is provided by the company.) Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing ...
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Kodiak Sciences Inc. KOD is a clinical-stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic and high-prevalence retinal diseases, which are the major causes of ...
Kodiak Sciences Inc KOD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kodiak Sciences, Inc.
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline ...
KOD Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate ...
Kodiak Sciences Inc (KOD)
As of late, it has definitely been a great time to be an investor in Kodiak Sciences Inc. (NASDAQ:KOD) . The stock has moved higher by 8.9% in the past month, while it is also... As of late, it ...
Loading the latest forecasts...